SCHOTT Pharma AG & Co. KGaA (1SXP) — Cash Flow Quality Index
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Cash Flow Quality Index of 2.24x as of September 2024. Operating cash flow of €75.97 Million exceeds net income of €33.97 Million, indicating high earnings quality where cash backs reported profits. Explore SCHOTT Pharma AG & Co. KGaA cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SCHOTT Pharma AG & Co. KGaA Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of SCHOTT Pharma AG & Co. KGaA to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for SCHOTT Pharma AG & Co. KGaA (2020–2024)
Year-by-year earnings quality comparison for SCHOTT Pharma AG & Co. KGaA. For live market cap and the full company financial profile, see 1SXP company net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.51x | €225.33 Million | €149.69 Million | ▲ +25.8% |
| 2023 | 1.20x | €181.65 Million | €151.84 Million | ▼ -17.6% |
| 2022 | 1.45x | €182.12 Million | €125.38 Million | ▲ +10.7% |
| 2021 | 1.31x | €132.21 Million | €100.75 Million | ▼ -2.6% |
| 2020 | 1.35x | €104.40 Million | €77.48 Million | — |